420 with CNW — Studies Find That Cannabis May Help with COVID-19 Recovery

February 24, 2022 16:25:00

New research has shown how cannabinoids may be helpful in post-COVID recovery.

Surviving the deadly coronavirus is not easy. In most cases, the virus damages the body in ways that can be felt even after an individual tests negative. The most common symptoms of the coronavirus include shortness of breath, colds, fever and a dry cough. The severity and duration of symptoms is different for every individual; some will experience the symptoms for a much longer period. Other symptoms include difficulty breathing, fatigue, stomach pains, chest pains, muscle pain, brain fog, heart palpitations and headaches.

The primary compounds found in cannabis, such as CBD (cannabidiol) and THC (tetrahydrocannabinol), have shown promise in earlier studies for treating and preventing the coronavirus. The studies have found that these compounds also help patients recover quickly.

One of these studies found that CBD and CVN (cannabivarin), which is another cannabinoid found in the cannabis plant, can treat long COVID. The researchers discovered that when CVN and CBD were administered simultaneously, they helped down-regulate proteins such as IL-6, NRP1, TSP and ACE2, which the coronavirus damages or upregulates during infection.

A separate study carried out by Rabin Medical Center researchers conducted an analysis of CBD’s impact on 11 patients with severe coronavirus infections. Eight of these patients recorded improvements in their infections. However, more studies with a bigger group of participants are needed to support these findings. Dr. Iliya Kagan, who is in charge of the ICU unit at Rabin Medical Center, explained that health-care providers saw a decrease in signs of the coronavirus infection after cannabis oil was administered.

Another study conducted in the Klagenfurt Hospital that involved physicians using marijuana to treat patients with the coronavirus also indicated that CBD was a promising treatment. This is the only hospital in Austria that uses CBD to treat patients with coronavirus infections. Dr. Rudolf Likar, who was a part of this study, stated that they administered CBD to 50 patients and noted a drop in levels of infection.

For their study, the doctors administered 200mg of cannabidiol to patients in the intensive care unit, then upped the dosage to 300mg after a period of time. They discovered that patients who received cannabidiol healed from this deadly infection much faster than those who received other medications. The researchers theorize that CBD could help boost the immune system because of its anti-inflammatory compounds; they do indicate that more research needs to be done to confirm the findings.

Such research suggests that users of cannabis products made by companies such as American Cannabis Partners may be deriving wellness benefits that are yet to be fully documented.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

Denver, Colorado
303.498.7722 Office

CNW420 is part of the InvestorBrandNetwork.